Avian flu: WHO prepares for the worst

Andresen, Margot
March 2004
CMAJ: Canadian Medical Association Journal;3/2/2004, Vol. 170 Issue 5, p777
Academic Journal
Provides information on the outbreak of avian flu in Asia and the preventive measures taken by the Health Canada and the World Health Organization (WHO). Number of people killed by avian flu in Asia as of February 9, 2004; Advice given by Health Canada to health care professionals; Possible results of avian flu according to Doctor Arlene King, director of immunology and respiratory infections for Heath Canada; Number of vaccines to be deployed by WHO.


Related Articles

  • Responding to the Avian Flu Threat: Balancing Risks and Rewards. Shuster, Michael J. // BioPharm International;Feb2006, Vol. 19 Issue 2, p28 

    The article reports that human infections with avian flu strain are occurring in Southeast Asian countries which have experienced outbreaks of avian influenza. The risks posed by the virus to the human population and the steps to be taken to minimize its impact are evaluated. The potential of...

  • Personal Protective Equipment and Risk for Avian Influenza (H7N3). Morgan, Oliver; Kuhne, Mirjam; Nair, Pat; Verlander, Neville Q.; Preece, Richard; McDougal, Marianne; Zambon, Maria; Reacher, Mark // Emerging Infectious Diseases;Jan2009, Vol. 15 Issue 1, p59 

    An outbreak of avian influenza (H7N3) among poultry resulted in laboratory-confirmed disease in 1 of 103 exposed persons. Incomplete use of personal protective equipment (PPE) was associated with conjunctivitis and influenza-like symptoms. Rigorous use of PPE by persons managing avian influenza...

  • Avian influenza.  // Nursing Standard;10/11/2006, Vol. 21 Issue 5, p58 

    A quiz concerning symptoms and prevention for avian influenza is presented.

  • Finding the real case-fatality rate of H5N1 avian influenza. Li, F. C. K.; Choi, B. C. K.; Sly, T.; Pak, A. W. P. // Journal of Epidemiology & Community Health;Jun2008, Vol. 62 Issue 6, p555 

    Background: Accurate estimation of the case-fatality (CF) rate, or the proportion of cases that die, is central to pandemic planning. While estimates of CF rates for past influenza pandemics have ranged from about 0.1% (1957 and 1968 pandemics) to 2.5% (1918 pandemic), the official World Health...

  • Update: Influenza Activity—United States and Worldwide, 2003-04 Season, and Composition of the 2004-05 Influenza Vaccine.  // JAMA: Journal of the American Medical Association;9/22/2004, Vol. 292 Issue 12, p1420 

    Presents a report that summarizes information collected by the World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System collaborating laboratories, state and local health departments, health-care providers and others related to influenza activity in the...

  • High Probability of Avian Influenza Virus (H7N7) Transmission from Poultry to Humans Active in Disease Control on Infected Farms. Bos, Marian E. H.; te Beest, Dennis E.; van Boven, Michiel; van Beest Holle, Mirna Robert Du Ry; Meijer, Adam; Bosman, Arnold; Mulder, Yonne M.; Koopmans, Marion P. G.; Stegeman, Arjan // Journal of Infectious Diseases;5/1/2010, Vol. 201 Issue 9, p1390 

    An epizootic of avian influenza (H7N7) caused a large number of human infections in The Netherlands in 2003. We used data from this epizootic to estimate infection probabilities for persons involved in disease control on infected farms. Analyses were based on databases containing information on...

  • Avian alert. Firth, Niall // Engineer (00137758);10/31/2005, Vol. 293 Issue 7687, p8 

    No abstract available.

  • Targeting surveillance.  // Veterinary Record: Journal of the British Veterinary Association;12/8/2007, Vol. 161 Issue 23, p765 

    The article discusses various reports published within the issue including one by L.C. Snow et al on risk-based surveillance for H5N1 avian influenza virus in wild birds in Great Britain and another by B.A. Valentine and C.V. Lohr on myonecrosis in three horses.

  • Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine. Ichinohe, Takeshi; Tamura, Shin-ichi; Kawaguchi, Akira; Ninomiya, Ai; Imai, Masaki; Itamura, Shigeyuki; Odagiri, Takato; Tashiro, Masato; Takahashi, Hidehiro; Sawa, Hirofumi; Mitchell, William M.; Strayer, David R.; Carter, William A.; Chiba, Joe; Kurata, Takeshi; Sata, Tetsutaro; Hasegawa, Hideki // Journal of Infectious Diseases;11/1/2007, Vol. 196 Issue 9, p1313 

    Background. Avian H5N1 influenza A virus is an emerging pathogen with the potential to cause substantial human morbidity and mortality. We evaluated the ability of currently licensed seasonal influenza vaccine to confer cross-protection against highly pathogenic H5N1 influenza virus in mice....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics